Bronchodilator responsiveness using spirometry in healthy and asthmatic preschool children

Luis Miguel Borrego1, Janet Stocks, Isabel Almeida

  • 1Departamento de Imunologia, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Campo dos Mártires da Pátria 123, Lisboa 1150-227, Portugal. borregolm@gmail.com

Insights

Spirometry is repeatable and reproducible in preschool children with asthma. Bronchodilator responsiveness (BDR) can be reliably assessed using FEV(0.75) in wheezy preschoolers.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Physiology
  • Clinical Trials

Background:

  • Spirometry is crucial for diagnosing and monitoring respiratory conditions in children.
  • Assessing lung function and bronchodilator responsiveness (BDR) in preschool children presents unique challenges due to variability.
  • Reliable spirometry measurements are essential for accurate asthma diagnosis and management in young children.

Purpose of the Study:

  • To evaluate the repeatability and reproducibility of spirometry measurements in healthy and asthmatic preschool children aged 3-6 years.
  • To determine the reliability of assessing bronchodilator responsiveness (BDR) in this age group.
  • To establish reference values for spirometry and BDR in preschool children.

Main Methods:

  • Spirometry was conducted before and after administering placebo or salbutamol.
  • Measurements were repeated on two separate occasions, 3-23 days apart, to assess reproducibility.
  • Forced expired volume in 0.75 s (FEV(0.75)) and forced mid-expiratory flows (FEF(25-75)) were the primary outcome measures.

Main Results:

  • Successful spirometry was achieved in 86% of participants.
  • Asthmatic children showed significantly lower baseline FEV(0.75) compared to healthy controls.
  • Bronchodilator responsiveness (FEV(0.75) increase) was significantly greater in asthmatic children post-salbutamol.
  • Between-occasion variability was higher in asthmatic children than in controls.

Conclusions:

  • Spirometry measurements, including bronchodilator responsiveness (BDR), can be reliably assessed in preschool children with asthma using FEV(0.75).
  • Consideration of within-subject variability and normal responsiveness in healthy children is important for accurate BDR assessment.
  • FEV(0.75) is a suitable parameter for evaluating BDR in wheezy preschoolers.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...